Delaware Attorney General Kathy Jennings announced a historic $26 billion settlement with the nationâs three major pharmaceutical distributors and one of its largest opioid manufacturers, which she said will help bring desperately needed relief to those struggling with opioid addiction.
The agreement resolves investigations and litigation over the role that Johnson & Johnson, Cardinal, McKesson and AmerisourceBergen played in creating and accelerating the opioid crisis, Jennings said.
Delaware stands to receive more than $100 million from the settlement â a sum second only to the tobacco master settlement agreement â over the course of 17 years, with $20 million coming to Delaware in the first year. The settlement will resolve claims against the three distributors in Delawareâs pending opioid lawsuit, though claims against other defendants â including Purdue Pharma, Endo Pharmaceuticals and Walgreens â remain ongoing.
Delaware nets about $100 million in opioid settlement
capegazette.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from capegazette.com Daily Mail and Mail on Sunday newspapers.
FDA Grants Meeting to Petros Pharmaceuticals to Discuss Label Expansion of Erectile Dysfunction Drug STENDRA®
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.